Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-21

Clinical Trial Update: Colchicine Use for Primary Prevention of Coronary Artery Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating colchicine for primary prevention of coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Qingdao Central Hospital | Conditions: Coronary Artery Disease | Phase 3 | Status: NOT_YET_RECRUITING